{
    "organizations": [],
    "uuid": "1aa691d8ecfd1025b8bf359bf6e166d0760a7cc1",
    "author": "",
    "url": "https://www.reuters.com/article/brief-eisai-submits-snda-to-fda-for-fyco/brief-eisai-submits-snda-to-fda-for-fycompa-pediatric-indications-idUSASC09UD3",
    "ord_in_thread": 0,
    "title": "BRIEF-Eisai Submits sNDA To FDA For Fycompa Pediatric Indications",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 30, 2018 / 7:13 PM / Updated 22 minutes ago BRIEF-Eisai Submits sNDA To FDA For Fycompa Pediatric Indications Reuters Staff \nMarch 30 (Reuters) - Eisai Inc : \n* EISAI SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) TO FDA FOR FYCOMPAÂ® (PERAMPANEL) PEDIATRIC INDICATIONS \n* EISAI INC - SUBMISSION ALSO PROPOSES PEDIATRIC INDICATION FOR MONOTHERAPY, ADJUNCTIVE USE FOR PGTC SEIZURES IN CHILDREN WITH EPILEPSY \n* EISAI INC SAYS SNDA IS FOR BOTH FYCOMPA TABLET AND ORAL SUSPENSION FORMULATIONS Source text for Eikon: Further company coverage:",
    "published": "2018-03-30T22:12:00.000+03:00",
    "crawled": "2018-03-30T22:47:51.011+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "submits",
        "snda",
        "fda",
        "fycompa",
        "pediatric",
        "indication",
        "reuters",
        "staff",
        "march",
        "reuters",
        "eisai",
        "inc",
        "eisai",
        "submits",
        "supplemental",
        "new",
        "drug",
        "application",
        "snda",
        "fda",
        "perampanel",
        "pediatric",
        "indication",
        "eisai",
        "inc",
        "submission",
        "also",
        "proposes",
        "pediatric",
        "indication",
        "monotherapy",
        "adjunctive",
        "use",
        "pgtc",
        "seizure",
        "child",
        "epilepsy",
        "eisai",
        "inc",
        "say",
        "snda",
        "fycompa",
        "tablet",
        "oral",
        "suspension",
        "formulation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}